EBOS Group Limited (ASX:EBO – Get Free Report) insider Tracey Batten bought 2,728 shares of the firm’s stock in a transaction that occurred on Thursday, October 30th. The shares were acquired at an average cost of A$24.76 per share, for a total transaction of A$67,531.64.
EBOS Group Stock Performance
The company has a debt-to-equity ratio of 66.89, a current ratio of 0.95 and a quick ratio of 0.76. The firm has a market cap of $8.20 billion, a PE ratio of 27.51 and a beta of 0.26.
EBOS Group Cuts Dividend
The business also recently declared a Final dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Tuesday, September 23rd were issued a $0.492 dividend. This represents a yield of 168.0%. The ex-dividend date of this dividend was Wednesday, September 3rd. EBOS Group’s dividend payout ratio is currently 72.14%.
EBOS Group Company Profile
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.
Featured Articles
- Five stocks we like better than EBOS Group
- What is the Dogs of the Dow Strategy? Overview and Examples
- Ford and GM Stocks Jump—Is the Auto Rebound Real?
- Dividend Capture Strategy: What You Need to Know
- Q3 Telecom Wars: How AT&T, TMUS and VZ Stack Up After the Results
- What is a Dividend King?
- Boeing Closes in on Airbus With Best Delivery Quarter Since 2018
Receive News & Ratings for EBOS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EBOS Group and related companies with MarketBeat.com's FREE daily email newsletter.
